Strategies for the use of Ginkgo biloba extract, EGb 761

Autor: Nagaendran, Kandiah, Yee Fai, Chan, Christopher, Chen, Darwin, Dasig, Jacqueline, Dominguez, Seol-Heui, Han, Jianping, Jia, SangYun, Kim, Panita, Limpawattana, Li-Ling, Ng, Dinh Toan, Nguyen, Paulus Anam, Ong, Encarnita, Raya-Ampil, Nor'izzati, Saedon, Vorapun, Senanarong, Siti, Setiati, Harjot, Singh, Chuthamanee, Suthisisang, Tong Mai, Trang, Yuda, Turana, Narayanaswamy, Venketasubramanian, Fee Mann, Yong, Yong Chul, Youn, Ralf, Ihl

Publikováno v: CNS Neuroscience & Therapeutics

Background Mild cognitive impairment (MCI) is a neurocognitive state between normal cognitive aging and dementia, with evidence of neuropsychological changes but insufficient functional decline to warrant a diagnosis of dementia. Individuals with MCI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cb354eb32c97c3d1bf23a2f595ed2ca3
https://pubmed.ncbi.nlm.nih.gov/33352000

Strategies for the use of Ginkgo biloba extract, EGb 761^®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus.

Autor: Kandiah, Nagaendran^1,2,3 (AUTHOR) nagaendran.kandiah@singhealth.com.sg, Chan, Yee Fai⁴ (AUTHOR), Chen, Christopher⁵ (AUTHOR), Dasig, Darwin⁶ (AUTHOR), Dominguez, Jacqueline⁷ (AUTHOR), Han, Seol‐Heui⁸ (AUTHOR), Jia, Jianping⁹ (AUTHOR), Kim, SangYun¹⁰ (AUTHOR), Limpawattana, Panita¹¹ (AUTHOR), Ng, Li‐Ling¹² (AUTHOR), Nguyen, Dinh Toan¹³ (AUTHOR), Ong, Paulus Anam¹⁴ (AUTHOR), Raya‐Ampil, Encarnita¹⁵ (AUTHOR), Saedon, Nor'izzati¹⁶ (AUTHOR), Senanarong, Vorapun¹⁷ (AUTHOR), Setiati, Siti¹⁸ (AUTHOR), Singh, Harjot¹⁹ (AUTHOR), Suthisisang, Chuthamanee²⁰ (AUTHOR), Trang, Tong Mai²¹ (AUTHOR), Turana, Yuda²² (AUTHOR)

Publikováno v: CNS Neuroscience & Therapeutics. Feb2021, Vol. 27 Issue 2, p149-162. 14p.